Unity Biotechnology, Inc. UBX
Set alert
0.20 0.00 0.00%
At close · Jul 2
0.2001 Day range 0.2001
0.947 52-week range 2.02
- YTD
- -79.51%
- 1 year
- -84.95%
- Open
- 0.2001
- Prev close
- 0.2001
- Mkt cap
- 16.85M
- Vol
- 0
- Avg vol
- 67.22K
- EPS
- -1.28
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.2001
- High
- 0.2001
- Forward P/E
- -0.57
- Beta
- 0.83
- Short ratio
- 3.52
- Inst. own
- 20.55%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 6, 2024
- 50-d avg
- 1.24
- 200-d avg
- 1.43
- 1y target
- 7.00
2Y chart
Events in this range
- Aug 9, 2023Rating: HC Wainwright & Co. · Buy → Buy
- Nov 14, 2023Rating: HC Wainwright & Co. · Buy → Buy
- Nov 16, 2023Rating: Wedbush · Neutral → Outperform
- Apr 15, 2024Earnings: —; estimate 0; surprise —%
- Apr 16, 2024Rating: HC Wainwright & Co. · Buy → Buy
- May 14, 2024Earnings: -0.34; estimate -0.57; surprise 40.35%
- May 14, 2024Earnings: —; estimate -0.57; surprise —%
- May 15, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Aug 6, 2024Earnings: -0.31; estimate -0.44; surprise 29.55%
- Aug 6, 2024Earnings: —; estimate -0.44; surprise —%
- Aug 8, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Nov 4, 2024Earnings: -0.38; estimate -0.4; surprise 5%
Signals (92)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Jul 23, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 30, 2025 | 1 year ago |
| RSI: Oversold | Jun 30, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 2, 2025 | 1 year ago |
| MACD: Sell Signal | May 28, 2025 | 1 year ago |
| MACD: Buy Signal | May 27, 2025 | 1 year ago |
| RSI: Oversold | May 14, 2025 | 1 year ago |
| MACD: Sell Signal | May 13, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 14, 2025 | 1 year ago |
| RSI: Oversold | Apr 4, 2025 | 1 year ago |
| RSI: Oversold | Mar 31, 2025 | 1 year ago |
| SMA: Bearish | Mar 24, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 24, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 14, 2025 | 1 year ago |
| SMA: Bearish | Feb 27, 2025 | 1 year ago |
| SMA: Bullish | Feb 26, 2025 | 1 year ago |
| SMA: Bearish | Feb 25, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 5, 2025 | 1 year ago |
| RSI: Overbought | Jan 22, 2025 | 1 year ago |
| SMA: Bullish | Jan 10, 2025 | 1 year ago |
| SMA: Bearish | Jan 8, 2025 | 1 year ago |
| SMA: Bullish | Jan 6, 2025 | 1 year ago |
| RSI: Overbought | Jan 6, 2025 | 1 year ago |
| SMA: Bullish | Jan 3, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 2, 2025 | 1 year ago |
| RSI: Oversold | Dec 18, 2024 | 1 year ago |
| MACD: Sell Signal | Dec 13, 2024 | 1 year ago |
| MACD: Buy Signal | Nov 26, 2024 | 1 year ago |
| MACD: Sell Signal | Nov 18, 2024 | 1 year ago |
| MACD: Buy Signal | Nov 13, 2024 | 1 year ago |
| RSI: Oversold | Nov 5, 2024 | 1 year ago |
| MACD: Sell Signal | Oct 16, 2024 | 2 years ago |
| SMA: Bearish | Oct 14, 2024 | 2 years ago |
| SMA: Bullish | Oct 11, 2024 | 2 years ago |
| SMA: Bullish | Oct 7, 2024 | 2 years ago |
| MACD: Buy Signal | Sep 27, 2024 | 2 years ago |
| SMA: Bearish | Sep 6, 2024 | 2 years ago |
| MACD: Sell Signal | Sep 5, 2024 | 2 years ago |
| SMA: Bullish | Aug 26, 2024 | 2 years ago |
| RSI: Overbought | Aug 26, 2024 | 2 years ago |
| MACD: Buy Signal | Aug 20, 2024 | 2 years ago |
| SMA: Bullish | Aug 19, 2024 | 2 years ago |
| MACD: Sell Signal | Aug 14, 2024 | 2 years ago |
| MACD: Buy Signal | Aug 13, 2024 | 2 years ago |
| SMA: Bullish | Aug 12, 2024 | 2 years ago |
| SMA: Bearish | Aug 9, 2024 | 2 years ago |
| SMA: Bullish | Aug 8, 2024 | 2 years ago |
| MACD: Sell Signal | Aug 5, 2024 | 2 years ago |
| SMA: Bearish | Aug 2, 2024 | 2 years ago |
| SMA: Bullish | Jul 30, 2024 | 2 years ago |
| SMA: Bearish | Jul 18, 2024 | 2 years ago |
| SMA: Bullish | Jul 12, 2024 | 2 years ago |
| MACD: Buy Signal | Jul 9, 2024 | 2 years ago |
| RSI: Oversold | Jun 18, 2024 | 2 years ago |
| SMA: Bearish | Jun 13, 2024 | 2 years ago |
| MACD: Sell Signal | Jun 13, 2024 | 2 years ago |
| SMA: Bullish | May 28, 2024 | 2 years ago |
| MACD: Buy Signal | May 28, 2024 | 2 years ago |
| MACD: Sell Signal | May 15, 2024 | 2 years ago |
| SMA: Bearish | May 14, 2024 | 2 years ago |
| SMA: Bullish | May 13, 2024 | 2 years ago |
| SMA: Bearish | May 10, 2024 | 2 years ago |
| SMA: Bullish | May 2, 2024 | 2 years ago |
| MACD: Buy Signal | Apr 26, 2024 | 2 years ago |
| MACD: Sell Signal | Apr 11, 2024 | 2 years ago |
| MACD: Buy Signal | Mar 25, 2024 | 2 years ago |
| SMA: Bullish | Feb 29, 2024 | 2 years ago |
| SMA: Bearish | Feb 28, 2024 | 2 years ago |
| MACD: Sell Signal | Feb 28, 2024 | 2 years ago |
| SMA: Bullish | Feb 22, 2024 | 2 years ago |
| SMA: Bearish | Feb 21, 2024 | 2 years ago |
| MACD: Buy Signal | Feb 6, 2024 | 2 years ago |
| MACD: Sell Signal | Feb 5, 2024 | 2 years ago |
| MACD: Buy Signal | Feb 2, 2024 | 2 years ago |
| MACD: Sell Signal | Jan 17, 2024 | 2 years ago |
| SMA: Bearish | Jan 11, 2024 | 2 years ago |
| SMA: Bullish | Dec 27, 2023 | 2 years ago |
| MACD: Buy Signal | Dec 27, 2023 | 2 years ago |
| MACD: Sell Signal | Dec 5, 2023 | 2 years ago |
| SMA: Bearish | Nov 27, 2023 | 2 years ago |
| SMA: Bullish | Nov 24, 2023 | 2 years ago |
| SMA: Bearish | Nov 22, 2023 | 2 years ago |
| SMA: Bullish | Nov 21, 2023 | 2 years ago |
| SMA: Bearish | Nov 20, 2023 | 2 years ago |
| SMA: Bullish | Nov 17, 2023 | 2 years ago |
| MACD: Buy Signal | Nov 17, 2023 | 2 years ago |
| MACD: Sell Signal | Nov 14, 2023 | 2 years ago |
| MACD: Buy Signal | Oct 26, 2023 | 3 years ago |
| MACD: Sell Signal | Oct 25, 2023 | 3 years ago |
| MACD: Buy Signal | Oct 18, 2023 | 3 years ago |
| RSI: Oversold | Oct 12, 2023 | 3 years ago |
| RSI: Oversold | Oct 3, 2023 | 3 years ago |
Key statistics
- Market cap
- 16.85M
- Enterprise value
- 11.57M
- Trailing P/E
- 0.00
- Forward P/E
- -0.57
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 1.19
- EPS (TTM)
- -1.28
- Beta
- 0.83
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- -10.16M
- Total cash
- 29.04M
- Total debt
- 24.43M
- Return on equity
- -86.95%
- Shares outstanding
- 16.85M
- Short % of float
- 1.55%
- 50-day average
- 1.24
- 200-day average
- 1.43
Analyst view
Consensus: none
Price target (mean) 7.00 +3398.3% upside
Now 0.2001
- Target (low)
- 6.00
- Target (mean)
- 7.00
- Target (high)
- 8.00
Ratings (0m) 2 2 buy · 0 hold · 0 sell
- Strong buy1
- Buy1
- Hold0
- Sell0
- Strong sell0
Next earnings
Aug 6, 2024
Expected Aug 6, 2024. Consensus EPS estimate -0.43443.
Financials — quick view
UBX Revenue — quarterly 0
UBX Net income — quarterly -7.30M
UBX EPS — quarterly -0.43
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 4, 2024 | Sep 1, 2024 | -0.40 | -0.38 | +0.02 | +5.00% |
| Aug 6, 2024 | Jun 1, 2024 | -0.44 | -0.31 | +0.13 | +29.55% |
| Aug 6, 2024 | Jun 1, 2024 | -0.44 | — | — | — |
| May 14, 2024 | Mar 1, 2024 | -0.57 | -0.34 | +0.23 | +40.35% |
| May 14, 2024 | Mar 1, 2024 | -0.57 | — | — | — |
| Apr 15, 2024 | Dec 1, 2023 | 0.00 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 8, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| May 15, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| Apr 16, 2024 | HC Wainwright & Co. | main | Buy | Buy |
| Nov 16, 2023 | Wedbush | up | Neutral | Outperform |
| Nov 14, 2023 | HC Wainwright & Co. | reit | Buy | Buy |
| Aug 9, 2023 | HC Wainwright & Co. | reit | Buy | Buy |
About Unity Biotechnology, Inc.
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase 2 clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular degeneration, and diabetic retinopathy. It also develops UBX1967 for the treatment of ophthalmologic diseases; UBX2048, a Tie2/VEGF bispecific; UBX2050, a human anti-Tie2 agonist monoclonal antibody for the treatment of eye diseases; and UBX2089, a a-Klotho hormone drug candidate for multiple neurology indications. The company was formerly known as Forge, Inc. and changed its name to Unity Biotechnology, Inc. in January 2015. Unity Biotechnology, Inc. was incorporated in 2009 and is headquartered in South San Francisco, California.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- unitybiotechnology.com
News
- UBX Tanzania Deepens Partnership with ACI Worldwide to Power the Next Phase of the Nation's Digital Economy
- 12 Health Care Stocks Moving In Tuesday's Intraday Session
- 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- US Stocks Likely To Open Higher: S&P 500 Sees 'Average Gain Of 6.1%' In 2nd Half, Expert Says
- 12 Health Care Stocks Moving In Tuesday's After-Market Session
- 12 Health Care Stocks Moving In Monday's Intraday Session
- 12 Health Care Stocks Moving In Tuesday's Intraday Session
- PTC Therapeutics To Rally Around 61%? Here Are 10 Top Analyst Forecasts For Tuesday
- UNITY Biotechnology to Present at the ARVO 2025 Annual Meeting
- UNITY Biotechnology, Inc. Reports First Quarter 2025 Financial Results and Business Updates
Your note
Sign in to keep a note on UBX — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| DANANBERG JAMIE | Officer | Sale | Mar 30, 2023 | 62,817 |
| GHOSH ANIRVAN | Chief Executive Officer | Sale | Nov 3, 2024 | 75,893 |
| NGUYEN ALEXANDER HIEU | Officer | Sale | Nov 3, 2024 | 24,723 |
| SULLIVAN LYNNE MARIE | Officer | Sale | Nov 3, 2024 | 55,925 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Arch Venture Management, Llc | 5.96% | 1,004,817 | 1.00M | Sep 29, 2024 |
| Alyeska Investment Group, L.p. | 5.46% | 920,013 | 919.74K | Sep 29, 2024 |
| Vanguard Group Inc | 3.51% | 590,770 | 590.59K | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.97% | 163,242 | 163.19K | Sep 29, 2024 |
| Mayo Clinic | 0.74% | 124,081 | 124.04K | Sep 29, 2024 |
| Renaissance Technologies, LLC | 0.56% | 93,670 | 93.64K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.35% | 395,985 | 395.87K | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 1.16% | 194,785 | 194.73K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.52% | 88,367 | 88.34K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.16% | 27,636 | 27.63K | Oct 30, 2024 |
| Bridgeway Funds Inc-Ultra Small Company Market Fund | 0.15% | 25,000 | 24.99K | Sep 29, 2024 |
| Fidelity Series Total Market Index Fund | 0.12% | 20,964 | 20.96K | Oct 30, 2024 |